An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis - PubMed (original) (raw)
. 1997 May 1;57(9):1814-9.
Affiliations
- PMID: 9135027
An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis
R Choudhuri et al. Cancer Res. 1997.
Abstract
Recent analysis of bladder tumors has correlated expression of the neurokine midkine (MK) with poor patient survival. To examine a role for MK and the related pleiotrophin (PTN) in tumorigenesis, they were overexpressed in MCF-7 breast carcinoma cells. Expression had no effect on in vitro growth but conferred a growth advantage in vivo. Enhanced tumor growth correlated with increased vascular density and endothelial proliferation, implicating an angiogenic role for MK and PTN. Angiogenic activity of MK and PTN was confirmed in the rabbit corneal assay. Our data therefore identify two novel targets for antiangiogenic drug development.
Similar articles
- Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
Weber D, Klomp HJ, Czubayko F, Wellstein A, Juhl H. Weber D, et al. Cancer Res. 2000 Sep 15;60(18):5284-8. Cancer Res. 2000. PMID: 11016659 - Pleiotrophin induces formation of functional neovasculature in vivo.
Christman KL, Fang Q, Kim AJ, Sievers RE, Fok HH, Candia AF, Colley KJ, Herradon G, Ezquerra L, Deuel TF, Lee RJ. Christman KL, et al. Biochem Biophys Res Commun. 2005 Jul 15;332(4):1146-52. doi: 10.1016/j.bbrc.2005.04.174. Biochem Biophys Res Commun. 2005. PMID: 15949466 - Pleiotrophin and midkine in normal development and tumor biology.
Kurtz A, Schulte AM, Wellstein A. Kurtz A, et al. Crit Rev Oncog. 1995;6(2):151-77. Crit Rev Oncog. 1995. PMID: 8792088 Review. - Midkine and pleiotrophin in neural development and cancer.
Kadomatsu K, Muramatsu T. Kadomatsu K, et al. Cancer Lett. 2004 Feb 20;204(2):127-43. doi: 10.1016/S0304-3835(03)00450-6. Cancer Lett. 2004. PMID: 15013213 Review. - Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angiogenesis.
Perez-Pinera P, Berenson JR, Deuel TF. Perez-Pinera P, et al. Curr Opin Hematol. 2008 May;15(3):210-4. doi: 10.1097/MOH.0b013e3282fdc69e. Curr Opin Hematol. 2008. PMID: 18391787 Review.
Cited by
- BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesothelioma.
Bisceglia L, Morani F, Guerrieri L, Santoni-Rugiu E, Çakılkaya P, Scatena C, Scarpitta R, Engelholm LH, Behrendt N, Gemignani F, Landi S. Bisceglia L, et al. Cancer Gene Ther. 2024 Sep 12. doi: 10.1038/s41417-024-00805-4. Online ahead of print. Cancer Gene Ther. 2024. PMID: 39300217 - Breg-Mediated Immunoregulation in the Skin.
Zheremyan EA, Ustiugova AS, Karamushka NM, Uvarova AN, Stasevich EM, Bogolyubova AV, Kuprash DV, Korneev KV. Zheremyan EA, et al. Int J Mol Sci. 2024 Jan 2;25(1):583. doi: 10.3390/ijms25010583. Int J Mol Sci. 2024. PMID: 38203754 Free PMC article. Review. - Nasopharynx Battlefield: Cellular Immune Responses Mediated by Midkine in Nasopharyngeal Carcinoma and COVID-19.
Kam NW, Lau CY, Che CM, Lee VH. Kam NW, et al. Cancers (Basel). 2023 Oct 4;15(19):4850. doi: 10.3390/cancers15194850. Cancers (Basel). 2023. PMID: 37835544 Free PMC article. Review. - Adenovirus as a Vector and Oncolytic Virus.
Matsunaga W, Gotoh A. Matsunaga W, et al. Curr Issues Mol Biol. 2023 Jun 2;45(6):4826-4840. doi: 10.3390/cimb45060307. Curr Issues Mol Biol. 2023. PMID: 37367056 Free PMC article. Review. - Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration.
Ding L, Wang N, Wang Q, Fan X, Xin Y, Wang S. Ding L, et al. Cell Death Discov. 2023 Mar 11;9(1):92. doi: 10.1038/s41420-023-01392-3. Cell Death Discov. 2023. PMID: 36906597 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources